Concerning ovarian cancer, high NTR1 mRNA expression, in a cohort of 491 high-grade ovarian serous cystadenocarcinoma patients from TCGA database, was linked to a significantly worse prognosis with shorter progression-free survival. Here, NTSR1 is linked to ovarian serous cystadenocarcinoma.